亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Nucleotide-based Carbohydrate Vaccines

技術優勢: Powerful method to produce vaccineExhaustive antigen epitope spaceHigh throughput

詳細技術說明: The invention relates to a method of directedevolution of a large library of carbohydrate-oligonucleotide conjugates, andthen a therapeutically-useful monoclonal antibody is used to bind those membersof the library which best resemble its native epitope. Through amplification ordiversification of the best binders from the first library, the best epitopemimics are selected from subsequent library generations to provide improvedbinders. The carbohydrate-oligonucleotide conjugates obtained from the processpresent carbohydrates in an environment similar to that of the natural epitope.Such a compound, when formulated with the appropriate immunogenic carrier andadjuvant, would constitute a vaccine.

*Abstract: Certain monoclonal antibodies have therapeutic potentialagainst a particular disease, even though similar antibodies seldom or neverarise during disease progression in most humans. In such cases, a "reverseimmunology" approach would be desirable, in which an immunogen is designedwhich structurally mimics the epitope of the therapeutically useful monoclonalantibody. Immunization with this epitope mimic would then elicit an antibodyresponse mimicking the monoclonal antibody.
The success of this strategy depends on theextent to which one can design a molecule that is a good structural andconformational mimic of the native epitope. Carbohydrates are necessary epitopescomponent for antibody binding. Carbohydrates are flexible and may exhibitdifferent conformational profiles when attached to structures other than thosepresent in the actual target protein. Good vaccine can be produced, if thetarget protein epitope can be faithfully mimicked using backbone ofcarbohydrates embedded in the oligonucleotide framework.

欲了解更多信息，請點擊這裡